Guardian Pharmacy Services, Inc.
GRDN Healthcare Medical Care Facilities
Guardian Pharmacy Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 17.9% from fiscal 2024.
- Revenue
- −1.68%
- EPS
- +133.3%
- Free cash flow
- +88.9%
Quarter to September 2026, against a year earlier
Follow GRDN
Alert me
Guardian Pharmacy Services, Inc. (GRDN) Net income
Guardian Pharmacy Services, Inc.'s net income for fiscal 2025 was $49.0M, compared with −$71.0M in fiscal 2024. Over the twelve months to 30 September 2026 it was $76.1M. Guardian Pharmacy Services, Inc. ranks 23rd of 50 Medical Care Facilities companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | $49.0M | — |
| FY2024 | −$71.0M | — |
| FY2023 | $37.7M | — |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Sep 2026 | $19.1M | (13.57%) |
| Jun 2026 | $22.1M | 63.33% |
| Mar 2026 | $13.5M | (36.31%) |
| Dec 2025 | $21.3M | 121.67% |
| 9 more quarters | Free account |
Net income against peers
| Company | Net income |
|---|---|
| AVAH Aveanna Healthcare Holdings Inc. compare | $274.8M |
| MD Pediatrix Medical Group, Inc. compare | $150.1M |
| NHC National HealthCare Corporation compare | $116.0M |
| ADUS Addus HomeCare Corporation compare | $111.1M |
| SGRY Surgery Partners, Inc. compare | $81.9M |
| GRDN Guardian Pharmacy Services, Inc. | $76.1M |
| ASTH Astrana Health, Inc. compare | $39.2M |
| BKD Brookdale Senior Living Inc. compare | −$138.4M |
| ACHC Acadia Healthcare Company, Inc. compare | −$1.1B |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on GRDN
- Revenue
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- The full statement